31 related articles for article (PubMed ID: 10586129)
1. Areolar sebaceous gland hyperplasia.
Kelly K; Weir K; Gardner R
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38123325
[No Abstract] [Full Text] [Related]
2. Perceptions, Utilization, and Cost Assessment of Sebaceous Hyperplasia Treatment Modalities: A Pilot Survey.
Millan SH; Sellyn GE; Friedman AJ
J Drugs Dermatol; 2024 Feb; 23(2):29-37. PubMed ID: 38306143
[TBL] [Abstract][Full Text] [Related]
3. Current concepts of the pathogenesis of acne: implications for drug treatment.
Gollnick H
Drugs; 2003; 63(15):1579-96. PubMed ID: 12887264
[TBL] [Abstract][Full Text] [Related]
4. Premature sebaceous hyperplasia in an adolescent boy.
Wang Q; Liu JM; Zhang YZ
Pediatr Dermatol; 2011; 28(2):198-200. PubMed ID: 21371111
[TBL] [Abstract][Full Text] [Related]
5. [Diffuse (presenile) hyperplasia of the sebaceous glands, a new entity? Successful treatment with 13-cis-retinoic acid].
Kaufmann R; Vranes M; Landes E
Hautarzt; 1987 Jan; 38(1):31-5. PubMed ID: 3470271
[TBL] [Abstract][Full Text] [Related]
6. Sebaceous hyperplasia: systemic treatment with isotretinoin.
Tagliolatto S; Santos Neto Ode O; Alchorne MM; Enokihara MY
An Bras Dermatol; 2015; 90(2):211-5. PubMed ID: 25830991
[TBL] [Abstract][Full Text] [Related]
7. Premature sebaceous hyperplasia with satisfactory response to oral isotretinoin.
Wang W; Qiu Y; Zhou G; Pei Z; Zhang F
Indian J Dermatol Venereol Leprol; 2016; 82(1):113. PubMed ID: 26728839
[No Abstract] [Full Text] [Related]
8. Isotretinoin as monotherapy for sebaceous hyperplasia.
Yu C; Shahsavari M; Stevens G; Liskanich R; Horowitz D
J Drugs Dermatol; 2010 Jun; 9(6):699-701. PubMed ID: 20645535
[TBL] [Abstract][Full Text] [Related]
9. Familial nevoid sebaceous gland hyperplasia affecting three generations of a family.
Weisshaar E; Schramm M; Gollnick H
Eur J Dermatol; 1999 Dec; 9(8):621-3. PubMed ID: 10586129
[TBL] [Abstract][Full Text] [Related]
10. Presenile diffuse familial sebaceous hyperplasia successfully treated with low-dose isotretinoin: A report of two cases and review of the published work.
Liu YS; Cheng YP; Liu CI; Yang CY; Yang CY
J Dermatol; 2016 Oct; 43(10):1205-1208. PubMed ID: 27130181
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic modulation of sebaceous gland activity: mechanisms and clinical applications.
Clarke SB; Nelson AM; George RE; Thiboutot DM
Dermatol Clin; 2007 Apr; 25(2):137-46, v. PubMed ID: 17430751
[TBL] [Abstract][Full Text] [Related]
12. Familial syringoma: report of two cases with a published work review and the unique association with steatocystoma multiplex.
Marzano AV; Fiorani R; Girgenti V; Crosti C; Alessi E
J Dermatol; 2009 Mar; 36(3):154-8. PubMed ID: 19335690
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
